Welcome to the Rutgers
Robert Wood Johnson Medical School and Princeton University
Research in medical and biological science relies more on interdisciplinary thought than ever before. The prevalence of team-oriented, collaborative research requires that investigators have the capacity to integrate both the clinical and basic science aspects of medicine. With rapid growth in the body of knowledge and technological sophistication comes the demand that future physician scientists receive in-depth training within and across conventional disciplines in order to excel in basic, translational, and clinical research.
Our program draws on the diverse strengths and resources of premier private and public research institutions and healthcare centers in central New Jersey to facilitate a unique academic environment in which students can hone and integrate their clinical and research acumen.
Drawing on experiences in both clinical medicine and basic research, past and present students in our program have investigated the pathologic mechanisms underlying human disease in diverse fields including:
- Genetic disease basis
- Biomedical engineering
- Drug design
- Infectious disease
In addition to clinical and basic-science proficiency, the RWJMS program includes opportunities for professional development, global health work, and the study of health policy and management. Our goal is to ensure that graduates of the MD/PhD program at RWJMS are uniquely prepared to become leaders in biomedical research, academic medicine, and prevention of disease.
Congratulations Jeremy Tang for receiving a NJCCR pre-doctoral fellowship entitled " "TRIM33's Role in DNA Repair and Endogenous Retrotransposon Suppression".
Congratulations to Bekah Gensure and Charles Miller for matching into the following Ophthalmology residency programs: Moran Eye Center at the University of Utah in Salt Lake City (Bekah) and SUNY Downstate Medical Center (Charles)
- November 2015:
Check out our very own student Heather McGowan talking about creating a stem cell model of Down Syndrome
Click here to watch the video!
- August 2015:
Alex Lorestani and his Princeton labmate Nick Ouzounov were awarded $250,000 by the IndieBio accelerator program to start a biotechnology company. They are leveraging synthetic biology to create a product with applications in the food, pharmaceutical and cosmetic industries. Their company is headquartered in San Francisco, CA.
- July 2015:
Congratulations Ben Deverett (PhD 1 Princeton PI: Sam Wang) and Vince Mirabella (PhD 2 Rutgers PIs: Zhiping Pang MDPhD and Davide Comoletti PhD) on receiving the 2015 NIMH MD/PhD Molecular Psychiatry travel award!!
- May 2015: Margaret MacGibeny was awarded a F30 fellowship: "cytokine-induced antiviral responses in axons of peripheral nervous system neurons”
- April 2015: Heather McGowan was awarded a travel stipend in April 2015 from The 1st International Conference of the Trisomy 21 Research Society: "Changing Paradigms in Down Syndrome" in Paris, France.
Katie Morgan was awarded a F30 NIH Grant- "MicroRNAs mediating Notch signaling in lung adenocarcinoma"
- If you are an alumnus of our program, please update your contact information using this online form. We would love to hear from you!
James Millonig, PhD Perry Dominguez Tina Cicolella
Program Director Program Coordinator Program Assistant